Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Teva Provigil ‘Pay For Delay’ Fines Should Stand, AG Says
Firm Has Appealed Decisions Leading To €60m EU Fines
Apr 01 2025
•
By
Dave Wallace
A CJEU advocate general has recommended rejecting Teva’s appeal
(Shutterstock)
More from Legal & IP
More from Policy & Regulation